ArticleJournal for immunotherapy of cancer2026
Evaluating the potential of candidate surrogate endpoints for overall survival in treatment-naive metastatic melanoma treated with anti-PD-1-based regimens with or without anti-CTLA-4 therapy.
Pierre Squifflet et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.